Castle Biosciences (CSTL) Financials

Castle Biosciences Inc (CSTL) is a biotechnology company that specializes in the development and commercialization of diagnostic and prognostic tests for patients with underserved cancers. The company's tests are designed to provide physicians with actionable information to improve patient care and outcomes. Castle Biosciences Inc (CSTL) generates revenue through the sale of its tests and related services to hospitals, physicians, and other healthcare providers.

The company's income statement shows its financial performance over a specific period. It includes details such as total revenue, gross profit, operating expenses, and net income. Castle Biosciences Inc (CSTL) has consistently reported impressive total revenue growth, driven by increasing demand for its diagnostic tests. The company's gross profit margin has also remained strong, indicating efficient cost management.

Castle Biosciences Inc (CSTL) measures its profitability through metrics such as EBIT (earnings before interest and taxes) and EBITDA (earnings before interest, taxes, depreciation, and amortization). These metrics provide insight into the company's ability to generate profits from its core operations. Castle Biosciences Inc (CSTL) has achieved steady EBIT and EBITDA growth, reflecting its strong business model and market position.

The company's balance sheet provides an overview of its financial health and position at a specific point in time. It includes key details such as cash equivalents, net debt, stockholders' equity, total assets, total debt, and total liabilities. Castle Biosciences Inc (CSTL) has maintained a solid balance sheet, with healthy cash equivalents and stockholders' equity. The company's total assets have also been steadily increasing, indicating its growth and investment in research and development.

Castle Biosciences Inc (CSTL) manages its cash flow through various activities, including financing, investing, and operating. The company's cash flow statement shows the sources and uses of cash during a specific period. Castle Biosciences Inc (CSTL) has consistently generated positive operating cash flow, highlighting its ability to generate cash from its core operations. The company's investing and financing cash flows have varied based on its strategic priorities and funding requirements.

In summary, Castle Biosciences Inc (CSTL) has demonstrated strong financial performance and stability through its income statement, balance sheet, and cash flow statement. The company's focus on developing and commercializing diagnostic tests has driven its revenue growth and profitability. Castle Biosciences Inc (CSTL) continues to invest in research and development to expand its portfolio and provide innovative solutions for patients with underserved cancers.